← Open Payments lookup

DIEGO LOAIZA: Open Payments

NPI 1033526413 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$846 in 48 payments from 15 companies in 2025. Trend: 2023 $1,094 · 2024 $687 · 2025 $846

Food & beverage: $814Education: $32
CompanyPaymentsAmount
Novo Nordisk Inc14$239
AstraZeneca Pharmaceuticals LP9$143
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$69
Gilead Sciences, Inc.4$68
Exact Sciences Corporation3$63
Boehringer Ingelheim Pharmaceuticals, Inc.3$54
Lilly USA, LLC2$40
Amgen Inc.2$32
LeMaitre Vascular, Inc.1$25
Medtronic, Inc.1$24

Products named: FARXIGA, XIFAXAN, JARDIANCE, Ozempic, Cologuard Collection Kit, BREZTRI, Rybelsus, ARTEGRAFT VASCULAR GRAFT.

Industry payments across NJ — which companies pay providers there.